A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Moderate to Severe Refractory Autoimmune Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Renji Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Hong Cai) · 18621576622@163.com · +86 18621576622
Contact: Principal Investigator (Hong Cai)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases

Moderate to Severe Refractory Autoimmune Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China